Bob Hopkins
Stock Analyst at B of A Securities
(0.71)
# 2,990
Out of 4,433 analysts
31
Total ratings
59.09%
Success rate
-15.86%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $5.34 | -15.73% | 4 | Sep 13, 2023 | |
| INSP Inspire Medical Systems | Maintains: Buy | $310 → $355 | $155.22 | +128.71% | 2 | Jul 5, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | n/a | $68.10 | - | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $104.09 | +27.77% | 2 | Aug 31, 2021 | |
| SWAV ShockWave Medical | Downgrades: Neutral | n/a | $330.13 | - | 2 | Jul 12, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | n/a | $9.00 | - | 2 | Mar 10, 2021 | |
| AFIB Acutus Medical | Downgrades: Neutral | n/a | $0.06 | - | 2 | Jan 14, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | n/a | $398.82 | - | 3 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $203.53 | - | 1 | Sep 8, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $154.64 | - | 1 | Apr 22, 2020 | |
| NVRO Nevro | Upgrades: Buy | n/a | $11.40 | - | 3 | Mar 20, 2019 | |
| TNDM Tandem Diabetes Care | Upgrades: Neutral | n/a | $47.30 | - | 2 | Aug 24, 2018 | |
| MDT Medtronic | Maintains: Buy | n/a | $85.92 | - | 1 | Aug 22, 2018 | |
| BAX Baxter International | Maintains: Buy | n/a | $35.25 | - | 1 | May 22, 2018 | |
| BSX Boston Scientific | Maintains: Buy | n/a | $74.65 | - | 1 | Apr 5, 2018 | |
| BDX Becton, Dickinson and Company | Reinstates: Buy | n/a | $236.30 | - | 1 | Jan 19, 2018 | |
| GMED Globus Medical | Upgrades: Neutral | n/a | $64.40 | - | 1 | Nov 10, 2017 | |
| MMSI Merit Medical Systems | Initiates: Buy | n/a | $81.89 | - | 1 | Jul 20, 2017 |
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $5.34
Upside: -15.73%
Inspire Medical Systems
Jul 5, 2023
Maintains: Buy
Price Target: $310 → $355
Current: $155.22
Upside: +128.71%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: n/a
Current: $68.10
Upside: -
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $104.09
Upside: +27.77%
ShockWave Medical
Jul 12, 2021
Downgrades: Neutral
Price Target: n/a
Current: $330.13
Upside: -
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: n/a
Current: $9.00
Upside: -
Acutus Medical
Jan 14, 2021
Downgrades: Neutral
Price Target: n/a
Current: $0.06
Upside: -
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $398.82
Upside: -
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $203.53
Upside: -
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $154.64
Upside: -
Nevro
Mar 20, 2019
Upgrades: Buy
Price Target: n/a
Current: $11.40
Upside: -
Tandem Diabetes Care
Aug 24, 2018
Upgrades: Neutral
Price Target: n/a
Current: $47.30
Upside: -
Medtronic
Aug 22, 2018
Maintains: Buy
Price Target: n/a
Current: $85.92
Upside: -
Baxter International
May 22, 2018
Maintains: Buy
Price Target: n/a
Current: $35.25
Upside: -
Boston Scientific
Apr 5, 2018
Maintains: Buy
Price Target: n/a
Current: $74.65
Upside: -
Becton, Dickinson and Company
Jan 19, 2018
Reinstates: Buy
Price Target: n/a
Current: $236.30
Upside: -
Globus Medical
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $64.40
Upside: -
Merit Medical Systems
Jul 20, 2017
Initiates: Buy
Price Target: n/a
Current: $81.89
Upside: -